Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
PACMen
1 other identifier
interventional
13
1 country
1
Brief Summary
Recent research has indicated that physical activities incorporating moderate-intensity exercise can be safely performed during treatment and substantially reduces treatment-related side effects, such as fatigue, sleep disturbances, cognitive impairment, and nausea. However, little is known about physical activity levels prior to treatment and whether providing an exercise intervention pre-treatment may improve functional capacity during treatment. The purpose of this study is to
- 1.Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and
- 2.Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:
- 3.Examine intervention safety and tolerance by self-report
- 4.Examine changes in functional capacity by 6-minute walk test
- 5.Examine changes in symptom experience by self-report
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable prostate-cancer
Started Apr 2018
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedStudy Start
First participant enrolled
April 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2019
CompletedAugust 26, 2019
August 1, 2019
11 months
November 1, 2017
August 22, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Change in 6 minute walk test
Distance walked in 6 minutes
baseline, 2 weeks post intervention
Change in balance test
Ability to balance
baseline, 2 weeks post intervention
Change in time up to go test
Time to get up from chair, walk 30 meters and return to sit in chair
baseline, 2 weeks post intervention
Change in Godin Leisure Time Score
physical activity score
baseline, 2 weeks post intervention
Change in rate of perceived exertion
physical exertion score
baseline, 2 weeks post intervention
Change in metabolic equivalent
metabolic activity score
baseline, 2 weeks post intervention
Change in distress score
distress score
baseline, 2 weeks post intervention
Change in self-efficacy score
self-efficacy score
baseline, 2 weeks post intervention
Change in symptom inventory score
description of symptoms
baseline, 2 weeks post intervention
Study Arms (1)
subjects with prostate cancer
EXPERIMENTALInterventions
Subjects will undergo pre-intervention measures, complete a daily physical activity diary, and post-intervention measures
Eligibility Criteria
You may qualify if:
- Newly diagnosed with prostate cancer
- will not start treatment for at least 2 weeks
- able to read and understand English
- capable of giving informed consent
- at least 18 years old
You may not qualify if:
- patients who are incompetent for interview (documented diagnosis of active psychosis or dementia)
- unable to provide informed consent as assessed by the interviewer
- too sick to participate, as judged by a member of the research team or the exercise physiologist
- have been treated for another cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke Raleigh Cancer Center
Raleigh, North Carolina, 27606, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Allen
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2017
First Posted
November 6, 2017
Study Start
April 17, 2018
Primary Completion
March 21, 2019
Study Completion
March 21, 2019
Last Updated
August 26, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share
No plan to share feasibility study data